Adult human mesenchymal stromal cells and the treatment of graft versus host disease

References

• RuhlHBeinGSachsUJTransfusion-associated graft-versus-host diseaseTransfus Med Rev200923627119056035
   PubMed Web of Science ®Google Scholar
• MurphyJThe effect of adult chick organ graft on the chick embryoJ Exp Med1916241619868024
   PubMedGoogle Scholar
• SimonsenMThe impact on the developing embryo and newborn animal of adult homologous cellsActa Pathol Microbiol Scand19574048050013457893
   PubMedGoogle Scholar
• BillinghamREBrentLQuantitative studies on tissue transplantation immunity. IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt diseasePhil Trans R Soc B Biol Sci1959242439
   Web of Science ®Google Scholar
• ThomasEDLochteHLJrLuWCFerrebeeJWIntravenous infusion of bone marrow in patients receiving radiation and chemotherapyN Engl J Med195725749149613464965
   PubMed Web of Science ®Google Scholar
• BortinMMA compendium of reported human bone marrow transplantsTransplantation197095715874911417
   PubMed Web of Science ®Google Scholar
• van RoodJJOudshoornMEleven million donors in bone marrow donors worldwide! Time for reassessment?Bone Marrow Transplant2008411917982505
   PubMed Web of Science ®Google Scholar
• BillinghamREThe biology of graft-versus-host reactionsHarvey Lect19666221784875305
   PubMedGoogle Scholar
• SacksteinRA revision of Billingham’s tenets: the central role of lymphocyte migration in acute graft-versus-host diseaseBiol Blood Marrow Transplant2006121 Suppl 12816399577
   PubMed Web of Science ®Google Scholar
• DeegHJAntinJHThe clinical spectrum of acute graft-versus-host diseaseSemin Hematol200643243116412786
   PubMed Web of Science ®Google Scholar
• PrzepiorkaDWeisdorfDMartinP1994 Consensus Conference on Acute GVHD GradingBone Marrow Transplant1995158258287581076
   PubMed Web of Science ®Google Scholar
• PaczesnySDiscovery and validation of graft-versus-host disease biomarkersBlood201312158559423165480
   PubMed Web of Science ®Google Scholar
• MacMillanMLWeisdorfDJWagnerJEResponse of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systemsBiol Blood Marrow Transplant2002838739412171485
   PubMed Web of Science ®Google Scholar
• DeegHJHow I treat refractory acute GVHDBlood20071094119412617234737
   PubMed Web of Science ®Google Scholar
• MartinPJInamotoYFlowersMECarpenterPASecondary treatment of acute graft-versus-host disease: a critical reviewBiol Blood Marrow Transplant20121898298822510383
   PubMed Web of Science ®Google Scholar
• MartinPJRizzoJDWingardJRFirst- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow TransplantationBiol Blood Marrow Transplant2012181150116322510384
   PubMed Web of Science ®Google Scholar
• WeidenPLFlournoyNThomasEDAntileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow graftsN Engl J Med19793001068107334792
   PubMed Web of Science ®Google Scholar
• TruittRLThe Mortimer M. Bortin Lecture: to destroy by the reaction of immunity: the search for separation of graft-versus-leukemia and graft-versus-hostBiol Blood Marrow Transplant20041050552315282529
   PubMed Web of Science ®Google Scholar
• ToubaiTSunYReddyPGVHD pathophysiology: is acute different from chronic?Best Pract Res Clin Haematol20082110111718503979
   PubMed Web of Science ®Google Scholar
• SakodaYHashimotoDAsakuraSDonor-derived thymic-dependent T cells cause chronic graft-versus-host diseaseBlood20071091756176417032915
   PubMed Web of Science ®Google Scholar
• FilipovichAHWeisdorfDPavleticSNational Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group reportBiol Blood Marrow Transplant20051194595616338616
   PubMed Web of Science ®Google Scholar
• SocieGRitzJMartinPJCurrent challenges in chronic graft-versus-host diseaseBiol Blood Marrow Transplant201016Suppl 1S146S15119836455
   PubMed Web of Science ®Google Scholar
• FassilHBassimCWMaysJOral chronic graft-vs-host disease characterization using the NIH scaleJ Dent Res201291Suppl 745S51S22699667
   PubMed Web of Science ®Google Scholar
• FilipovichAHDiagnosis and manifestations of chronic graft-versus-host diseaseBest Pract Res Clin Haematol20082125125718503990
   PubMed Web of Science ®Google Scholar
• DominiciMLe BlancKMuellerIMinimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy2006831531716923606
   PubMed Web of Science ®Google Scholar
• Le BlancKTammikCRosendahlKZetterbergERingdenOHLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cellsExp Hematol20033189089614550804
   PubMed Web of Science ®Google Scholar
• Bocelli-TyndallCBracciLSpagnoliGBone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitroRheumatology (Oxford)20074640340816920750
   PubMed Web of Science ®Google Scholar
• CorcioneABenvenutoFFerrettiEHuman mesenchymal stem cells modulate B-cell functionsBlood200610736737216141348
   PubMed Web of Science ®Google Scholar
• NautaAJWesterhuisGKruisselbrinkABLurvinkEGWillemzeRFibbeWEDonor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingBlood20061082114212016690970
   PubMed Web of Science ®Google Scholar
• SpaggiariGMMorettaLCellular and molecular interactions of mesenchymal stem cells in innate immunityImmunol Cell Biol201391273123146943
   PubMed Web of Science ®Google Scholar
• ChoudheryMSBadowskiMMuiseAHarrisDTComparison of human mesenchymal stem cells derived from adipose and cord tissueCytotherapy20131533034323318344
   PubMed Web of Science ®Google Scholar
• UccelliAMorettaLPistoiaVMesenchymal stem cells in health and diseaseNat Rev Immunol2008872673619172693
   PubMed Web of Science ®Google Scholar
• MalgieriAKantzariEPatriziMPGambardellaSBone marrow and umbilical cord blood human mesenchymal stem cells: state of the artInt J Clin Exp Med2010324826921072260
   PubMed Web of Science ®Google Scholar
• KempKCHowsJDonaldsonCBone marrow-derived mesenchymal stem cellsLeuk Lymphoma2005461531154416236607
   PubMed Web of Science ®Google Scholar
• SundinMRingdenOSundbergBNavaSGotherstromCLe BlancKNo alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipientsHaematologica2007921208121517666368
   PubMed Web of Science ®Google Scholar
• SpeesJLGregoryCASinghHInternalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapyMol Ther2004974775615120336
   PubMed Web of Science ®Google Scholar
• BernardoMEAvanziniMAPerottiCOptimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substituteJ Cell Physiol200721112113017187344
   PubMed Web of Science ®Google Scholar
• FeketeNGadelorgeMFurstDPlatelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active componentsCytotherapy20121454055422296115
   PubMed Web of Science ®Google Scholar
• FossettEKhanWSOptimising human mesenchymal stem cell numbers for clinical application: a literature reviewStem Cells Int2012201246525922448172
   PubMed Web of Science ®Google Scholar
• SantosFAndradePZAbecasisMMToward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditionsTissue Eng Part C Methods2011171201121021895491
   PubMed Web of Science ®Google Scholar
• KhanalSTomlinsonATear physiology in dry eye associated with chronic GVHDBone Marrow Transplant20124711511921383687
   PubMed Web of Science ®Google Scholar
• KramperaMGalipeauJShiYTarteKSensebeLImmunological characterization of multipotent mesenchymal stromal cells – The International Society for Cellular Therapy (ISCT) working proposalCytotherapy2013151054106123602578
   PubMed Web of Science ®Google Scholar
• ProckopDJDefining the probability that a cell therapy will produce a malignancyMol Ther2010181249125020596063
   PubMed Web of Science ®Google Scholar
• CasiraghiFRemuzziGAbbateMPericoNMultipotent mesenchymal stromal cell therapy and risk of malignanciesStem Cell Rev20139657922237468
   PubMed Web of Science ®Google Scholar
• von BahrLBatsisIMollGAnalysis of tissues following mesenchymal stromal cell therapy in humans indicate limited long-term engraftment and no ectopic tissue formationStem Cells2012301575157822553154
   PubMed Web of Science ®Google Scholar
• LucchiniGDanderEPavanFMesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantationStem Cells Int2012201269023622701127
   PubMed Web of Science ®Google Scholar
• MeiselRBrockersSHeselerKHuman but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenaseLeukemia20112564865421242993
   PubMed Web of Science ®Google Scholar
• WangJLiaoLWangSTanJCell therapy with autologous mesenchymal stem cells – how the disease process impacts clinical considerationsCytotherapy20131589390423751203
   PubMed Web of Science ®Google Scholar
• Le BlancKRasmussonISundbergBTreatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsLancet20043631439144115121408
   PubMed Web of Science ®Google Scholar
• Le BlancKFrassoniFBallLMesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II studyLancet20083711579158618468541
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.GovEfficacy and safety of adult human mesenchymal stem cells to treat steroid refractory acute graft versus host diseaseOsiris Therapeutics Available from: http://www.clinicaltrials.gov/ct2/show/NCT00366145?term=mesenchymal+stem+cells+AND+bone+marrow+transplantation&rank=16Accessed December 22, 2013
   Google Scholar
• GalipeauJThe mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?Cytotherapy2013152823260081
   PubMed Web of Science ®Google Scholar
• KuzminaLAPetinatiNAParovichnikovaENMultipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease – a Phase II studyStem Cells Int2012201296821322242033
   PubMed Web of Science ®Google Scholar
• YangYGWangHAsavaroengchaiWDeyBRRole of interferon-gamma in GVHD and GVLCell Mol Immunol2005232332916368058
   PubMed Web of Science ®Google Scholar
• KramperaMCosmiLAngeliRRole for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cellsStem Cells20062438639816123384
   PubMed Web of Science ®Google Scholar
• KramperaMMesenchymal stromal cell ‘licensing’: a multistep processLeukemia2011251408141421617697
   PubMed Web of Science ®Google Scholar
• ZhouHGuoMBianCEfficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical reportBiol Blood Marrow Transplant20101640341219925878
   PubMed Web of Science ®Google Scholar
• WengJHeCLaiPMesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host diseaseMol Ther2012202347235423070118
   PubMed Web of Science ®Google Scholar
• ProckopDJBrennerMFibbeWEDefining the risks of mesenchymal stromal cell therapyCytotherapy20101257657820735162
   PubMed Web of Science ®Google Scholar
• MenardCPacelliLBassiGClinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controlsStem Cells Dev2013221789180123339531
   PubMed Web of Science ®Google Scholar
• FoxJMChamberlainGAshtonBAMiddletonJRecent advances into the understanding of mesenchymal stem cell traffickingBr J Haematol200713749150217539772
   PubMed Web of Science ®Google Scholar
• YagiHSoto-GutierrezAParekkadanBMesenchymal stem cells: mechanisms of immunomodulation and homingCell Transplant20101966767920525442
   PubMed Web of Science ®Google Scholar
• HerrmannRSturmMShawKMesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 studyInt J Hematol20129518218822183779
   PubMed Web of Science ®Google Scholar
• ForbesGMSturmMJLeongRWA Phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapyClin Gastroenterol Hepatol201412647123872668
   PubMed Web of Science ®Google Scholar
• RingdenOUzunelMRasmussonIMesenchymal stem cells for treatment of therapy-resistant graft-versus-host diseaseTransplantation2006811390139716732175
   PubMed Web of Science ®Google Scholar
• FangBSongYLiaoLZhangYZhaoRCFavorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host diseaseTransplant Proc2007393358336218089385
   PubMed Web of Science ®Google Scholar
• von BoninMStolzelFGoedeckeATreatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumBone Marrow Transplant20094324525118820709
   PubMed Web of Science ®Google Scholar
• KebriaeiPIsolaLBahceciEAdult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host diseaseBiol Blood Marrow Transplant20091580481119539211
   PubMed Web of Science ®Google Scholar
• Perez-SimonJALopez-VillarOAndreuEJMesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trialHaematologica2011961072107621393326
   PubMed Web of Science ®Google Scholar
• MuroiKMiyamuraKOhashiKUnrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II studyInt J Hematol20139820621323860964
   PubMed Web of Science ®Google Scholar
• ZhangLSLiuQFHuangKZhangYFanZPHuangSLMesenchymal stem cells for treatment of steroid-resistant chronic graft-versus-host diseaseZhonghua Nei Ke Za Zhi200948542546 Chinese19957792
   PubMedGoogle Scholar
• WengJYDuXGengSXMesenchymal stem cell as salvage treatment for refractory chronic GVHDBone Marrow Transplant2010451732174020818445
   PubMed Web of Science ®Google Scholar